Wessanen Q4/ FY 2018 results: Moderate growth and improved

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
91
Wessanen Q4/ FY 2018 results: Moderate growth and improved profitability

Amsterdam, 12 February 2019 7:00 CET

Q4 2018 highlights

· Autonomous growth of own brands 5.9%, driven by strong promotional plans in France Grocery · Revenue growth of 5.2% includes a decline of private label and distribution business · EBITE of €14.8 million, up 47% versus prior year

Full year 2018 highlights

· Autonomous growth of own brands 2.1% · Revenue growth of 0.6% to €628.4 million · EBITE of €57.7 million, up 8% versus prior year · EBITE as % of Revenue up 60 bps versus last year to 9.2%

CEO statement

Christophe Barnouin (CEO) commented: "In 2018 the market for healthy and sustainable food continued to be very dynamic as many consumers are considering to make changes to their food habits. The market attracted more players leading to intensified competition. This put some of our growth plans under pressure resulting in an overall moderate level of growth, stronger in Q4 as a result of our corrective action plans.  For the full year  profitability was up as a result of better gross margins, lower share based payments and reduced A&P.

We continue to pursue our vision of building a different kind of food company, connected to nature in all we do. Of our total revenue, 77.5% is from organic and 96% from vegetarian products. We have completed the    B Corp certification of two more companies (Abafoods Italy and Germany) so that 70% of our business is now covered by the certification. We are on track to become the first multinational food business to be certified by 2020. The acquisition of Abbot Kinney's added a new, strategic and fast growing unit to our Dairy Alternatives category that we have integrated at high speed.

2018 was a year that brought with it some new challenges and not all our plans worked out. But it also confirmed again that as a business we are focused on the most promising segment of the food market and that we can respond to challenges resiliently and effectively while staying true to our purpose.

Looking ahead to 2019, we expect that the organic market will remain very dynamic. The Grocery channel will continue to take share from HFS. Conventional players, private label and smaller brands will continue to push into organic, putting pressure on established players in terms of growth, margin and brand support. We therefore expect low to moderate growth of own brands for the year.

 

Guidance FY 2019

· We expect low to moderate growth of own brands and a further reduction of private label and distribution brand sales · We expect EBITE as % of revenue to be in the range of 8 to 9% for the full year · Net financing costs around €2.0-2.5 million. This includes an impact of around €0.5 million regarding the implementation of IFRS 16 and around €0.5 million related to the unwinding discount of the contingent consideration for the Abbot Kinney's acquisition · Tax rate around 30% · Capital expenditure of €10-12 million · Depreciation and amortisation of €14-15 million. This includes an impact of around €4.3 million related to IFRS 16 and €0.4 million amortisation of the Gayelord Hauser brand after reclassification to a finite life

 

Important dates 2019

11-04-2019  AGM (14h00 CET) 18-04-2019  Publication Q1 2019 trading update 19-07-2019  Publication Q2 2019 interim results 18-10-2019  Publication Q3 2019 trading update

Analyst & investor meeting

At 10h00 CET, an analyst & investor meeting will be hosted by Christophe Barnouin (CEO) and Ronald Merckx (CFO) at the Wessanen head office in Amsterdam. The meeting can be followed via a live audio webcast at www.wessanen.com . Those unable to attend can participate using the following telephone number: +31 (0)20 531 5853. The press release and presentation are available for download at www.wessanen.com .

 

Media, investor & analyst enquiries

Ronald Merckx (CFO) Phone  +31 (0)20 3122 126 Email  ronald.merckx@wessanen.com Twitter @Wessanen_250

 

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading

Top 5 Most Recently Viewed Articles

BioVaxys Unveils Private Placement to Boost Growth Initiatives

Updated Category News Views 83

BioVaxys Technology Corp. Announces Private Placement Offering BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) is thrilled to share its plans for a strategic move that aims to elevate its operational capabilities. The company intends to initiate a non-brokered private placement offering, introducing up to 14,285,715 units at a price of CAD$0.07 each. This initiative is...

Continue Reading
Cardiff Oncology Secures $40 Million Through Oversubscribed Offering

Updated Category News Views 104

Cardiff Oncology Completes Significant Stock Offering Cardiff Oncology, Inc. (Nasdaq: CRDF) has recently made headlines with its successful pricing of an underwritten offering, targeting a remarkable $40 million. This offering consists of 15,384,619 shares of its common stock, priced at $2.60 per share, with all shares being offered by the Company itself. The...

Continue Reading
Sungrow and Globeleq Partner for Major Battery Storage Project

Updated Category News Views 301

Sungrow and Globeleq Join Forces on Groundbreaking Energy Project Sungrow, a prominent name in the renewable energy sector, and Globeleq, a trusted independent power producer, have made a significant commitment by signing a term sheet. This partnership focuses on the supply and long-term service for the ambitious 153MW / 612MWh Red Sands Battery Energy Storage System...

Continue Reading
Helios Technologies Unveils the Advanced S35 Display System

Updated Category News Views 442

Helios Technologies Launches the Versatile S35 Display Helios Technologies, Inc. (NYSE: HLIO), known for its expertise in highly engineered motion control and electronic controls technology, has recently introduced the S35 display. This new addition showcases a unique blend of advanced technology, rugged durability, and user-friendliness, making it an exceptional...

Continue Reading
Ameriprise Financial Soars to New Heights: Stock Insights

Updated Category News Views 47

Ameriprise Financial Achieves All-Time High Ameriprise Financial Inc (NYSE: AMP) has recently marked an extraordinary achievement with its stock price reaching an all-time high of $524.01. This significant increase not only highlights the company’s performance but also reflects a robust surge in investor confidence, demonstrated by a remarkable 65.08% increase over the...

Continue Reading